Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 13051-13100 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04142866
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
NARecruiting
30 participants
Started: Jan 3, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT06851247
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
PHASE2Recruiting
47 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06671704
GC-PRO Intervention
NARecruiting
994 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2026
5 conditions2 sponsors1 location
NCT06515691
Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy
NARecruiting
60 participants
Started: Jan 3, 2025 · Completed: Dec 15, 2025
4 conditions1 sponsor1 location
NCT06709989
Chemical and Microbiological Exposure of Women on Dairy Cattle Farms
N/ARecruiting
80 participants
Started: Jan 3, 2025 · Completed: Nov 30, 2027
1 condition3 sponsors1 location
NCT06762639
Improving Patient Sleep Prior to Elective Surgery
NARecruiting
154 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06710223
Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab
PHASE1Recruiting
20 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06627959
StatSeal vs Figure-of-Eight Suture for Vascular Closure in AF Ablation
NARecruiting
160 participants
Started: Jan 3, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06751836
Innovative Multidisciplinary Strategies for Combating Severe Dengue
N/ARecruiting
1,400 participants
Started: Jan 3, 2025 · Completed: Oct 31, 2029
4 conditions5 sponsors2 locations
NCT06720727
Craniospinal Irradiation in Histone AlteRed Midline Glioma
NARecruiting
32 participants
Started: Jan 3, 2025 · Completed: Nov 8, 2028
1 condition1 sponsor1 location
NCT06744907
Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
PHASE4Recruiting
60 participants
Started: Jan 3, 2025 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06539741
Variability in Analgesic Response to Ibuprofen
N/ARecruiting
200 participants
Started: Jan 3, 2025 · Completed: Sep 30, 2027
2 conditions2 sponsors1 location
NCT06747676
GRAViceptive NEGlect Treatment in Acute Stroke Using Targeted Cranial ELECTrotherapy
PHASE1/PHASE2Recruiting
28 participants
Started: Jan 3, 2025 · Completed: Jan 15, 2026
1 condition6 sponsors2 locations
NCT07038304
The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
PHASE2Recruiting
35 participants
Started: Jan 3, 2025 · Completed: Jan 3, 2029
4 conditions1 sponsor2 locations
NCT06766461
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
PHASE4Recruiting
980 participants
Started: Jan 3, 2025 · Completed: Dec 1, 2027
3 conditions3 sponsors1 location
NCT06764238
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
PHASE2/PHASE3Recruiting
1,800 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2031
3 conditions1 sponsor26 locations
NCT06849635
Cera™ ASD Occluder Post-Market Clinical Follow-Up Study
N/ARecruiting
139 participants
Started: Jan 3, 2025 · Completed: Feb 28, 2026
1 condition1 sponsor6 locations
NCT06822920
Post-Market Clinical Investigation Plan - Collagen Dura Membranes (DM & DMO)
N/ARecruiting
110 participants
Started: Jan 3, 2025 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT06748677
Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction
N/ARecruiting
484 participants
Started: Jan 3, 2025 · Completed: Dec 31, 2031
4 conditions1 sponsor1 location
NCT06189313
CLEANer Aspiration for Pulmonary Embolism
NARecruiting
125 participants
Started: Jan 3, 2025 · Completed: Sep 23, 2026
4 conditions2 sponsors16 locations
NCT06745622
Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE2Recruiting
47 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06636773
Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.
NARecruiting
290 participants
Started: Jan 3, 2025 · Completed: Feb 28, 2029
1 condition2 sponsors1 location
NCT07081256
To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
PHASE3Recruiting
664 participants
Started: Jan 3, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05626920
Disulfiram for Treatment of Retinal Degeneration
PHASE1/PHASE2Recruiting
30 participants
Started: Jan 3, 2025 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06938256
Suboccipital Muscle Inhibition Technique vs Rocabado Exercises on Cervicogenic Headache
NARecruiting
40 participants
Started: Jan 3, 2025 · Completed: Jul 15, 2025
1 condition1 sponsor1 location
NCT06589024
Remote STATE Training for Insomnia in Older Adults
NARecruiting
240 participants
Started: Jan 3, 2025 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06588478
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
PHASE2Recruiting
249 participants
Started: Jan 3, 2025 · Completed: Dec 31, 2028
2 conditions2 sponsors135 locations
NCT06585072
Pancreatic Cancer and Diabetes Mellitus
N/ARecruiting
150 participants
Started: Jan 3, 2025 · Completed: Sep 1, 2026
3 conditions1 sponsor1 location
NCT06710717
Autologous CD19 Car T-Cell Therapy For Severe Refractory Systemic Lupus Erythematosus (SLE)
PHASE1Recruiting
5 participants
Started: Jan 3, 2025 · Completed: Jan 2, 2029
1 condition2 sponsors1 location
NCT06769711
The Comparison of Tunnel Morphology and Graft Healing in Anterior Cruciate Ligament Reconstructions Using Peroneus Longus And Hamstring Tendons
NARecruiting
58 participants
Started: Jan 3, 2025 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT06770738
Correlation of the EUROSCORE-II With POSPOM in Cardiac Surgery: A Single Center, Retrospective, Cross- Sectional Study
N/ARecruiting
315 participants
Started: Jan 3, 2025 · Completed: Dec 30, 2025
6 conditions1 sponsor1 location
NCT06881511
Exploratory Study on the Efficacy of Betaine Hydrochloride in Treating Autoimmune Gastritis
NARecruiting
100 participants
Started: Jan 3, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT07036172
Efficacy and Safety of Semaglutide Injection Vs WEGOVY® in Chinese Obese Patients
PHASE3Recruiting
460 participants
Started: Jan 3, 2025 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06792214
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
PHASE4Recruiting
118 participants
Started: Jan 3, 2025 · Completed: Jan 31, 2027
1 condition4 sponsors4 locations
NCT06738615
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity
N/ARecruiting
40 participants
Started: Jan 2, 2025 · Completed: May 2, 2027
1 condition1 sponsor1 location
NCT06632002
Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes Who Require Nutritional Support
NARecruiting
100 participants
Started: Jan 2, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06846983
Peripheral Perfusion Index As an Early Predictor of Successful Caudal Block in Pediatric Patients Undergoing Lower Abdominopelvic Surgeries Under General Anesthesia
N/ARecruiting
60 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06641297
White Matter Plasticity in Schizophrenia
NARecruiting
36 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT06206941
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
N/ARecruiting
450 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2027
1 condition3 sponsors2 locations
NCT06802120
Effects of Osteopathic Management on Disability and Quality of Life After Lumbar Arthrodesis
NARecruiting
40 participants
Started: Jan 2, 2025 · Completed: May 31, 2027
1 condition3 sponsors1 location
NCT06640725
Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N
PHASE2Recruiting
70 participants
Started: Jan 2, 2025 · Completed: Dec 2, 2028
1 condition1 sponsor1 location
NCT06741657
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
PHASE1Recruiting
404 participants
Started: Jan 2, 2025 · Completed: Apr 8, 2026
1 condition1 sponsor2 locations
NCT06227910
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
PHASE3Recruiting
396 participants
Started: Jan 2, 2025 · Completed: Aug 1, 2028
1 condition1 sponsor138 locations
NCT06555328
Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa
PHASE2Recruiting
75 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2025
3 conditions1 sponsor29 locations
NCT06528158
Speech Groups for Children Living with a Sibling Who Suffers from Anorexia Nervosa
N/ARecruiting
24 participants
Started: Jan 2, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05884073
Exercise for Oncology Care Professionals
NARecruiting
70 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor2 locations
NCT06455527
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)
NARecruiting
100 participants
Started: Jan 2, 2025 · Completed: Nov 1, 2027
1 condition2 sponsors1 location
NCT06585631
The Collaborative Care PrTNER Study
NARecruiting
275 participants
Started: Jan 2, 2025 · Completed: Jun 30, 2028
4 conditions4 sponsors2 locations
NCT06769633
Pharmacokinetics and Safety of Givinostat in DMD Patients Ages From at Least 2 Years to Less Then 6 Years Old
PHASE2Recruiting
18 participants
Started: Jan 2, 2025 · Completed: Dec 31, 2029
1 condition2 sponsors9 locations
NCT04220190
RAPA-501 Therapy for ALS
PHASE2/PHASE3Recruiting
41 participants
Started: Jan 2, 2025 · Completed: Jun 1, 2027
1 condition2 sponsors1 location